对玻璃眼和视神经病变的治疗策略
Jung Lo1, Kamakshi Mehta2, Armaan Dhillon3
1Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, 83301, Taiwan.
Molecular aspects of medicine
|October 15, 2023
概括
青光眼治疗的目的是降低眼内压力 (IOP),但不能恢复视力. 像基因疗法和干细胞治疗等新兴疗法对视网膜质细胞 (RGC) 再生显示出有前途.
科学领域:
- 眼科医生 眼科 眼科
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
背景情况:
- 玻璃眼瘤是由于视网膜质细胞 (RGC) 和视神经退化导致的不可逆转视力丧失的主要原因.
- 升高的眼内压力 (IOP) 是主要的危险因素,但在正常的眼内压力下也会出现青光眼.
- 目前的治疗方法侧重于降低内血压以减缓疾病进展,而不是恢复视力.
研究的目的:
- 审查了解RGC发展和再生的当前进展.
- 探索基因疗法和干细胞移植治疗青光眼的潜力.
- 讨论基于RGC的青光眼治疗的未来前景和挑战.
主要方法:
- 关于RGC发育,视神经再生和干细胞分化最近研究的文献综述.
- 对当前的药理和手术干预措施进行分析.
- 评估新兴的治疗策略,包括基因治疗和干细胞移植.
主要成果:
- 药物治疗和微创性玻璃眼外科手术 (MIGS) 提供了改善的IOP管理,但不能逆转视力损失.
- 基因相关病毒基因转导和基于干细胞的RGC替代疗法为视神经修复提供了有前途的途径.
- 对RGC发育机制的进一步研究对于优化干细胞分化和基因治疗目标至关重要.
结论:
- 现有的玻璃眼治疗可以治疗IOP,但不能恢复失去的视力.
- 基因疗法和干细胞移植具有通过再生RGC和视神经纤维来治疗绿眼病的巨大潜力.
- 对RGC的发展和分化进行持续的研究对于推进青光眼的再生疗法至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
471
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
471
Angle Closure Glaucoma: Treatment
540
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
540
Glaucoma: Overview
600
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
600
Direct-Acting Cholinergic Agonists: Therapeutic Uses
772
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
772
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K
Cholinergic Antagonists: Therapeutic Uses
758
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
758


